POGO

  • Staff List
  • Contact Us

Main menu

Skip to primary content
Skip to secondary content
  • About Us
    • Our Mission and Vision
    • Childhood Cancer Care Plan
    • POGO Land Acknowledgement
    • Diversity, Equity, Inclusion
    • Our Board
    • Our Partners
    • Our Donors
    • Privacy
    • Accessibility
    • Reports
    • Newsroom
    • Job Opportunities
    • Staff List
  • Programs & Support
    • Patient Care Programs
    • Financial Assistance
    • Survivor Care
    • Cancer Resources
    • Inspiring Stories
    • Clinical and Program Advisory Committees
  • Education
    • POGO Virtual Education
    • Indigenous Resource Guide
    • All Education Events & Conferences
  • Healthcare Practice
    • COVID-19 Updates
    • Pediatric Oncology Nursing
    • Clinical Practice Guidelines
    • POGO Satellite Manual
  • Research & Data
    • 2020 POGO Surveillance Report
    • POGO Research Unit
    • POGONIS – Childhood Cancer Database
    • Data Reports
    • Data Requests
  • Get Involved
    • Pajamas and Pancakes
    • Birthday Parties for POGO
    • Events
    • Volunteer
  • Ways to Give
    • Donate
    • Gifts of Stock and Securities
    • Become a Corporate Partner
    • Gifts in Honour/Memory
    • Legacy Gifts
    • Shop Online/Earn Cash Back

Blog

POGO > Blog > BMT
[sharethis]

Tag: BMT


Post navigation

← Older posts

Long-Term Health-Related Outcomes in Survivors of Childhood Hematopoietic Cell Transplantation

Posted on March 6, 2014 by admin

Presentation Description:
HCT is frequently offered as a curative option for children with benign and malignant conditions. Improvements in HCT strategies have increased survival by approximately 10% per decade. In fact, long-term survival is an expected outcome for many children and adolescents who undergo HCT. The growing population of long-term survivors has brought to the medical forefront a host of chronic and debilitating conditions attributed to toxicity from pre-transplantation exposure, transplantation conditioning regimens, chronic immunosuppression, and GVHD. This presentation provided an overview of health-related outcomes in long-term survivors of childhood HCT, and compared these outcomes to survivors of conventionally treated cancer.

Speaker:

Saro Armenian, DO, MPH
Medical Director, Pediatric Survivorship Clinic, Childhood Cancer Survivorship Program
City of Hope, Los Angeles

Posted in 2014 AfterCare Education Day, Education for Health Professionals | Tagged 2014 AfterCare Education Day, BMT, chronic immunosuppression, Graft versus host disease (GVHD), Hematopoietic Stem Cell Transplant, hematopoietic-stem-cell transplantation, survivorship

Demystifying Blood and Marrow Transplantation

Posted on March 3, 2014 by admin


Presentation Description:
The continual advent of new and innovative therapies in the field of Blood and Marrow Transplantation has led to increasingly complicated patient care requirements. Comorbidities of disease and previous treatments render the accurate pre- transplant assessment of patients to be essential if care requirements are to be adequately anticipated and planned for. During the transplant admission many acute issues may arise as a result of the intensity of current treatment regimes. The post transplant period may see a continuation of these acute issues into a more chronic phase or the continued emergence of new issues.

As a transplant centre for patients from multiple referral hospitals it is recognized that information flow between centres regarding all phases of transplantation is essential for optimal care. This presentation provided an overview of the rationale for and the pre- transplant work-up required related to comorbidities and potential impact on care.  Additionally, current challenges of inpatient care were discussed. The information necessary and the process for organizing a safe return home to the original referring centre were also discussed.

Speakers:
Christine Armstrong, RN(EC), MScN,
Nurse Practitioner, Blood and Marrow Transplant Program
The Hospital for Sick Children, Toronto

Sarah Courtney, RN(EC), MN, NP Pediatrics
Nurse Practitioner, Blood and Marrow Transplant Program
The Hospital for Sick Children, Toronto

Mary Jo De Courcy, RN, MScN, CPHON
Nurse Practitioner, Oncology
Children’s Hospital, London Health Sciences Centre, London

Posted in 2013 Pre-Symposium Nursing Seminar - Innovation in Pediatric Oncology Nursing, Education for Health Professionals | Tagged 2013 Pre-Symposium Nursing Seminar, BMT, bone marrow transplant, comorbidities, Hematopoietic Stem Cell Transplant, patient care, referring centre

PTLD: A Primer

Posted on March 3, 2014 by admin


Presentation Description:
Post-transplant lymphoproliferative disease (PTLD) refers to a spectrum of pathologic and clinical presentations of premalignant and malignant B cell proliferation in the setting of altered immune function post solid organ or bone marrow transplantation This session introduced the epidemiology, pathology, and treatment of PTLD and provided recommendations for supportive care of children with PTLD.

Speaker:
Angela Punnett, MD, FRCPC
Pediatric Oncologist
The Hospital for Sick Children, Toronto
Assistant Professor, Department of Pediatrics
University of Toronto, Toronto

Posted in 2013 Pre-Symposium Nursing Seminar - Innovation in Pediatric Oncology Nursing, Education for Health Professionals | Tagged 2013 Pre-Symposium Nursing Seminar, BMT, post-transplant, PTLD

2011 POGO Symposium on Childhood Cancer

Posted on February 1, 2013 by admin

The 2011 POGO Multi-Disciplinary Symposium on Childhood Cancer – Unraveling the Mysteries of Transplantation – examined clinical and scientific advances in pediatric stem cell transplantation as treatment for various types of cancers.  It focused on the medical and psychosocial impacts of this intensive intervention on patients, families, donors and survivors, and examined important ethical issues.  A multi-disciplinary audience of over 270 healthcare professionals attended. Learning objectives included:

  • Recognize and examine critical milestones in the evolution of pediatric stem cell transplantation.
  • Identify and manage clinical complications affecting pediatric stem cell transplant patients.
  • Recognize and mitigate psychosocial effects of transplant on patients, families, donors and survivors.
  • Identify and evaluate ethical issues relating to pediatric stem cell transplantation.
  • Demonstrate improved communication skills to promote co-operative integrated management of pediatric stem cell transplant patients.

VIEW THE PROGRAM

NOTE: The content of each presentation below captures the unedited information and opinions presented by the speakers. Please note that the information contained in the presentations was current at the time it was presented – there may be further information in subsequent literature. Listed speaker credentials were current at the time of presentation.

Posted in 2011 Symposium, Education for Health Professionals | Tagged 2011 Symposium, BMT, bone marrow, Pediatric Stem Cell Transplantation, post-transplant, pre-transplant, stem cell, transplant

The Evolution of Pediatric Stem Cell Transplantation

Posted on February 1, 2013 by admin

Presentation Description: The field of haematopoietic stem cell transplantation (SCT) had its firm beginnings in paediatrcis with the first successful bone marrow transplant being performed in 1968 on a child with severe combined immune deficiency.  Today more than 15,000 allogeneneic SCTs are performed worldwide with around one quarter of those occurring in children suffering from a wide variety of malignant and genetic disorders.  There is no doubt that SCT represents one of the most innovative treatments of the last decades, and while the principles of SCT have remained the same, dramatic changes in the details of SCT over the last forty years have led to significant improvements in the outcome.  While many children are now cured from otherwise fatal disorders, much work is still required to reduce both acute toxicities, and specifically in children, the long-term side effects of these procedures.

Speaker:

Paul Veys, MBBS, FRCP, FRCPath, FRCPH
Director, Blood and Marrow Transplantation
Great Ormond Street Hospital for Children, London, England
Reader in Stem Cell Transplantation
UCL Institute of Child Health Molecular Immunology Unit

Posted in 2011 Symposium, Education for Health Professionals | Tagged 2011 Symposium, allogeneneic stem cell transplantation, BMT, bone marrow, haematopoietic stem cell transplantation, Pediatric Stem Cell Transplantation, stem cell, transplant

Post navigation

← Older posts

Donate

Blog

Education Portal
Survivor Conference
All Categories

Categories

Newsletter Sign-Up

Please leave this field empty

@POGO4Kids

January 30, 2023

We’re excited to have @TD_Canada as a POGO PJ Party sponsor! Thank you for the support to help ensure everyone affected by #childhoodcancer has access to the best care and support. Learn more here: http://pogopjparty.com #POGOPJParty

Reply on Twitter 1620130019392774144 Retweet on Twitter 1620130019392774144 Like on Twitter 1620130019392774144 3 Twitter 1620130019392774144

Follow @POGO4Kids

Quick Links

  • For Professionals
    • Read Cancer Care Plan
    • Review our Guidelines
    • Request Research Data
  • Families & Kids
    • Get POGO AfterCare
    • Meet with a POGO Nurse
    • Get Care Closer to Home
  • For Survivors
    • Find Local Resources
    • Set Goals for your Future
    • Educate Yourself
  • Get Involved
    • Host an Event for POGO
    • Volunteer with POGO
    • Partner with POGO
  • About Us
    • Our Mission and Vision
    • Childhood Cancer Care Plan
    • POGO Land Acknowledgement
    • Diversity, Equity, Inclusion
    • Our Board
    • Our Partners
    • Our Donors
    • Privacy
    • Accessibility
    • Reports
    • Newsroom
    • Job Opportunities
    • Staff List
  • Programs & Support
    • Patient Care Programs
    • Financial Assistance
    • Survivor Care
    • Cancer Resources
    • Inspiring Stories
    • Clinical and Program Advisory Committees
  • Education
    • POGO Virtual Education
    • Indigenous Resource Guide
    • All Education Events & Conferences
  • Healthcare Practice
    • COVID-19 Updates
    • Pediatric Oncology Nursing
    • Clinical Practice Guidelines
    • POGO Satellite Manual
  • Research & Data
    • 2020 POGO Surveillance Report
    • POGO Research Unit
    • POGONIS – Childhood Cancer Database
    • Data Reports
    • Data Requests
  • Get Involved
    • Pajamas and Pancakes
    • Birthday Parties for POGO
    • Events
    • Volunteer
  • Ways to Give
    • Donate
    • Gifts of Stock and Securities
    • Become a Corporate Partner
    • Gifts in Honour/Memory
    • Legacy Gifts
    • Shop Online/Earn Cash Back

©2022 Pediatric Oncology Group of Ontario

480 University Avenue, Suite 1014 | Toronto, Ontario, M5G 1V2, Canada | Charitable Registration Number: 871067245RR0001 |
1-855-FOR POGO (367-7646) | Contact Us | Website Privacy Policy | Website Disclaimer | Satellite Manual Disclaimer |